Cowealth Medical China Co.Ltd.603122
▼ NegativeCapitalrelevance
First-half net loss widened to 7.5 million yuan with revenue down 7.9% and operating cash flow down 83.6%.
Impact on stocks 1
Others
Cowealth Medical China Co.Ltd.Cowealth Medical released its 2026 interim report, showing its first-half net loss attributable to the parent widened to 7.5 million yuan. Operating revenue was 339 million yuan, down 7.9 percent year on year. Net loss attributable to the parent after deducting non-recurring items was 7.57 million yuan, and net operating cash flow was 14.23 million yuan, down 83.6 percent year on year. The company returned to profit in the second quarter, with net profit attributable to the parent of 790,000 yuan. The company said the operating environment has been affected by national centralized volume-based procurement policies for medical devices and in vitro diagnostic reagents, and the competitive landscape has been deeply reshaped, putting pressure on overall revenue and profitability.
Cowealth Medical China Co.Ltd.First-half net loss widened to 7.5 million yuan with revenue down 7.9% and operating cash flow down 83.6%.